-
Glecaprevir/pibrentasvir (G/P), sold
under the
brand names Mavyret and Maviret, is a fixed-dose
combination medication used to
treat hepatitis C. It contains...
-
Glecaprevir (INN,) is a
hepatitis C
virus (HCV)
nonstructural (NS)
protein 3/4A
protease inhibitor that was
identified jointly by
AbbVie and
Enanta Pharmaceuticals...
-
particles in patients' blood. HCV
genotype 1a (no cirrhosis): 8 w****s of
glecaprevir/pibrentasvir or ledipasvir/sofosbuvir (the
latter for
people who do not...
-
Daclatasvir Daclatasvir/sofosbuvir (daclatasvir + sofosbuvir)
Glecaprevir/pibrentasvir (
glecaprevir + pibrentasvir)
Ravidasvir Sofosbuvir Sofosbuvir/velpatasvir...
- inhibitors—class stem –previr: 26
Asunaprevir Boceprevir Grazoprevir Glecaprevir Paritaprevir Simeprevir Telaprevir 3-chymotrypsin-like
protease (including...
-
United States and Europe, it is
approved for use with
glecaprevir as the
combination drug
glecaprevir/pibrentasvir (trade name
Mavyret in the US and Maviret...
- side-chains Gutta-percha, used in
endodontic treatment to
obturate root
canals Glecaprevir/pibrentasvir,
medication used to
treat hepatitis C .gp, the Internet...
-
velpatasvir J05AP56 Sofosbuvir,
velpatasvir and
voxilaprevir J05AP57
Glecaprevir and
pibrentasvir J05AP58 Daclatasvir,
asunaprevir and
beclabuvir J05AR01...
- velpatasvir, and voxilaprevir)
Zepatier (elbasvir and grazoprevir)
Mavyret (
glecaprevir and pibrentasvir) The
United States Food and Drug
Administration approved...
- V600E
mutation Ibrutinib Pharmacyclics chronic graft-versus-host
disease Glecaprevir/pibrentasvir
AbbVie hepatitis C Cytarabine/daunorubicin
Celator Pharmaceuticals...
